Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20260329001Phase 3Completed
Phase 3, randomised trial of epinephrine in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Phramongkutklao Hospital Foundation. Started Mar 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20260329001.